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Momordica charantia, commonly known as bitter melon, is used as a vegetable in number of countries. 
Extracts of M. charantia plant, fruit pulp, and seed have been reported to have a wide medicinal use in 
the traditional medical systems, most often as hypoglycemic and anti-diabetic agents. We have studied 
the effect of M. charantia, collected from Kazdaglari (Mount Ida) in Balikesir, fruit extract on glutathione 
S-transferases (GSTs), cytochrome P450s (CYPs), and antioxidant enzymes in rats. Male Wistar rats, 
aged 12 weeks and weighing 200-250 g, were given 200 mg M. charantia fruit extract per kg body 
weight, i.p., for four consecutive days. At the end of the experimental period, the animals were 
sacrificed, and liver, kidney, and lung were isolated. Our results have indicated significant increase in 
especially hepatic antioxidant enzymes such as superoxide dismutase (SOD), catalase (CAT) and 
glutathione peroxidase (GPx) activities. The strongest increase (about 9-fold) was observed in GPx 
activities while about 2 to 5-fold increases were observed in SOD and CAT. M. charantia fruit extract 
also exhibited hepatoprotective effects in CCl4-intoxicated rats. In addition, about 50% increase was 
also noted with hepatic cytosolic GSTs. On the other hand, treatments of rats with M. charantia 
significantly reduced both ethoxyresorufin O-deethylase (EROD) and methoxyresorufin O-deethylase 
(MROD) activities in rat liver microsomes, which are known to be catalyzed by CYP1A isoforms These 
results suggest that the M. charantia fruit extract possesses the anti-oxidant effects besides having 
protective activities in rats.  
 






It is generally accepted that reactive oxygen species 
(ROS) and/or free radicals play an important role in the 
development of tissue damage and pathological events in 
living organisms (Kehrer, 1993; Halliwel and Gutteridge, 
1999). There are increasing evidences that increased 
consumption of fruits and vegetables and intake of 
certain nonnutrients that are present in foods reduce the 
risk of various pathological events such as cancer 
(Goodwin and Brodwick, 1995; Steinmetz and Potter, 
1996) and cardio- and cerebro-vascular diseases (Rimm 
et al., 1996). This is often attributed to the antioxidants in 
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noids, lycopenes and flavonoids that prevent free radical 
damages (Stahelin et al., 1991; Steinberg, 1991; Willett, 
1994). Thus, much attention has been focused on the 
investigation of antioxidants that can scavenge ROS, 
especially natural antioxidants, phenolic and flavonoids 
from plants which are mostly used as protective agents 
against free radical-mediated diseases (Shahidi and 
Wanasundra, 1992; Rice-Evans et al., 1996). In addition, 
the traditional use of medicinal plants or their crude 
extracts in the prevention and/or treatment of several 
chronic diseases has been increasingly practiced in 
various different ethnic societies worldwide. 
This study was designed to specifically investigate the 
antioxidant and chemoprotective efficacy of Momordica 
charantia fruit extract by investigating antioxidant 
enzymes, cytochrome P450s (CYPs) and glutathione S-
transferases (GSTs) in Wistar rat  liver,  lung  and  kidney 




tissues when it is administered in vivo.  
The antioxidant enzymes (AOE) include superoxide 
dismutase (SOD), catalase (CAT), glutathione peroxidase 
(GPx) and indirectly glutathione reductase (GR). Their 
role as protective enzymes are well known and have 
been extensively investigated both in vivo and in vitro in 
model systems. Cytochrome P450 (CYP, EC 1.14.14.1) 
enzymes are active in monooxygenation and 
hydroxylation of various xenobiotics, including drugs, 
carcinogens, environmental pollutants as well as many 
endogenous substrates, fatty acids, arachidonic acids, 
steroids, prostaglandins, leukotrienes (Nebert and 
Gonzales, 1987; Zimniak and Waxman, 1993). 
Glutathione S-transferases (GST, EC 2.5.1.18) are a 
complex multigene family of enzymes that are widely 
distributed in the animal kingdom (Snyder and Maddison, 
1997). The most important function of GST is 
detoxification, conjugating reduced glutathione with a 
large number of electrophilic metabolites derived from a 
variety of xenobiotics, including carcinogens, toxins and 
drugs. GSTs are also involved in the metabolism of 
endogenous substances such as leukotriene and 
prostaglandins. 
Momordica charantia L. (Cucurbitaceae) known as 
bitter melon, balsam pear, Karela, etc. is a vegetable 
indigenous to tropical areas including India, Asia, South 
America and Africa and cultivated throughout South 
America as food and medicine. Various preparations of 
M. charantia from injectable extracts to fruit juice to dried 
fruit bits have been traditionally used worldwide, 
particularly for blood-sugar lowering effects (Welihinda et 
al., 1986; Raman and Lau, 1996). In addition, it has been 
reported to exhibit diverse biological activities such as 
antioxidant, antimicrobial, antiviral, antihepatotoxic and 
antiulcerogenic activities which are attributed to an array 
of biologically active plant chemicals including 
triterpenes, pisteins and steroids (Grover and Yadav, 
2004). 
Although M. charantia is not a native plant in Turkey, 
the fruits, known as “kudret nari”, are frequently used in 
folk medicine, especially in west and southwest part of 
Anatolia for the treatment of peptic ulcers and tumors. 
Recently, the plant is being cultivated in Western 
Anatolia. In the view of ethnomedical reports M. charantia 
is being used in folkloric medicine on various ulcers, 
diabetes and infections (Gurbuz et al., 2000; Scartezzini 
and Speroni, 2000; Beloin et al., 2005). Thus, present 
study was undertaken to further characterize the 
biological activities of M. charantia.  
 
 




The fruits of M. charantia were collected in the fall of 2003 and 
2004 from the foot of Kazdaglari (Mount Ida), Balikesir, Turkey.  
Mount Ida, which is also very popular in mythology due to its role 










The collected fruits, air-dried and fine powdered, were extracted 
with hexane using soxhlet extraction apparatus according to the 
Soxhlet’s method where materials are extracted by repeated 
percolation which lasts about 6 - 8 h with hexane under reflux in a 
special glassware. At the end of extraction process, the solvent is 
then evaporated and the remaining mass is measured. The 
percentage yields are calculated as mg per g dried fruits. Finally, 






Male Wistar rats (12-14 weeks old) weighing 200-250 g were used. 
They were housed University Animal House in standard conditions 
and fed with standard diet with water ad libitum. All experimental 
procedures in animals such as administration of substances by i.p., 
collection of blood and tissue etc. are performed to the national 
standards under appropriate regimes with Veterinary services and 
licensed projects. Rats were randomly assorted into the following 
four groups (each group consisting of 8-20 rats). Group I (control) 
some rats were treated with DMSO-water mixture, i.p. daily for 4 
days; Group II (Mom) rats were treated with M. charantia fruit 
extract 200 mg/kg, i.p. daily for 4 consecutive days; Group III (CCl4) 
rats were administered with CCl4 to induce hepatotoxicity at dose of 
10 mg CCl4/kg, i.p. daily for 2 consecutive days; and Group IV 
(Mom + CCl4) rats were pretreated with 200 mg/kg; i.p. daily for 4 
consecutive days prior to administration of CCl4 10 mg CCl4/kg, i.p. 
daily for 2 consecutive days. 
At the end of experimental period, the rats were anesthetized 
with ether following a 16-hr fasting. Blood samples were taken from 
aorta to determine the serum enzymes. The livers, lungs and 
kidneys were removed and rinsed with cold physiological saline and 





1-chloro-2,4-dinitrobenzene (CDNB), alanine, aspartic acid, bovine 
serum albumin (BSA), glutathione reduced (GSH), H2O2, 
glutathione reductase, methoxy- and ethoxyresorufin, cholic acid, -
nicotinamide adenine dinucleotide phosphate (-NADPH) and 
pyrogallol were purchased from Sigma (USA). All other chemicals 
and solvents were of highest purity and analytical grade. 
 
 
Preparation of tissues subcellular fractions 
 
The tissues were homogenized in 5 parts homogenization solution 
(1.15% KCl containing 250 mM EDTA, 100 mM 
phenylmethylsulphonylfluoride, 100 mM butylated hydroxytoluene, 
0.025% cholate) using a tissue homogenizer with a teflon pestle at 
4°C. The subcellular fractions of rat tissues were prepared by a 
standard differential centrifugation procedure as described 
previously (Sen and Kirikbakan, 2004). The amounts of proteins in 
various fractions were measured using the method of Lowry et al. 
(1951) with BSA as the standard.  
 
 
Determination of total antioxidant response 
 
Antioxidant capacity of M. charantia was determined by measuring  
total antioxidant response (TAR) against potent free radical reaction 





Determination of serum AST and ALT and LDH activities 
 
In order to evaluate hepatocellular damage and antihepatotoxic 
potential of the M. charantia fruit extract enzymatic leakage of 
transaminases [ALanine aminoTransferase (ALT) and ASpartate 
aminoTransferase (AST)] and Lactate DeHydrogenase (LDH) in 
serum were measured by the method of Raitman and Frankel 
(1957) and Wroblewski and La Due (1955), respectively. Blood was 
centrifuged at 4000 rpm at 4°C for 10 min to get serum.  
 
 
Determination of antioxidant enzyme activities 
 
SOD activity was measured by the method of Marklund and 
Marklund (1974). CAT activity was measured using Abei’s method 
(1974). The GPx activity was assayed by using Paglia and 
Valentine’s method (1967). 
 
 
Determination of phase I and phase II enzyme activities 
 
Cytochrome P450 dependent 7-ethoxyresorufin O-deethylase 
(EROD) and 7-methoxyresorufin O-deethylase (MROD) activities 
were determined by the fluorometric measurements of resorufin 
formed using the method of Burke and Mayer (1974) as optimized 
by Sen and Arinc (2000). GST activities using CDNB as substrate 





Results are expressed as mean ± SD of at least three 
determinations for each data point. One way ANOVA, Tukey and 
Dunnett tests were applied for analyzing the significance of differ-
ence between and among different groups. 
 
 
RESULTS AND DISCUSSION 
 
M. charantia fruit extract was studied for its antioxidant 
and chemoprotective effects by investigating antioxidant 
enzymes, cytochrome P450s and glutathione S-transfe-
rases as well as its protective effects on hepatocellular 
damage in CCl4-intoxicated rats were evaluated.  
Free radical scavenging effects of M. charantia fruit 
extract was tested by measuring total antioxidant status 
of M. charantia using a colorimetric method for the total 
antioxidant response (TAR) as described by Erel (2004). 
The relative total antioxidant response of M. charantia 
was determined 1.43 ± 0.02 mmol Trolox equiv/L, which 
was higher than 1 mM GSH, indicating potential antioxi-
dant properties of M. charantia fruit extract. The effects of 
M. charantia extract on the serum transaminases and 
LDH in control and CCl4-intoxicated rats are given in 
Table 1. Treatment of rats with M. charantia fruit extract 
alone did not alter the enzyme activities while in the CCl4-
intoxicated groups transaminases (ALT and AST) and 
LDH activities significantly increased (p<0.001). However, 
the rats pre-treated with M. charantia decreased signifi-
cantly these elevated transaminases and LDH activities 
(Table 1). CCl4 is a known hepatotoxic compound work-
ing through the generation of reactive free radicals. 
Treatment with M. charantia fruit extract was found to up 
regulate different antioxidant and detoxifying enzymes in 




liver of rats challenged with CCl4 as compared to control. 
Therefore, these results demonstrated that the fruit of M. 
charantia has protective function against CCl4 toxicity in 
rat liver when administered in vivo at a dose of 200 mg / 
kg/day i.p, for 4 consecutive days prior to CCl4 intoxica-
tion. Similar results have been reported for some other 
ethnobotanical fruits and herbs (Hsiao et al., 2003; Kim et 
al., 2003; Jung et al., 2004). 
Antioxidant actions of food may be through inhibitory 
actions on generation of ROS or by direct scavenging of 
free radicals. In addition, the levels of endogenous antio-
xidants may also be up regulated by increasing expres-
sion of the genes encoding the antioxidant enzymes 
SOD, CAT and GPx. AOE and antioxidant molecules can 
inhibit free radical production by chelating the transition 
metal catalysts, breaking chain reactions, reducing 
concentrations of ROS and/or scavenging initiating radi-
cals (Aruoma, 1994; Halliwel and Gutteridge, 1999). In 
order to investigate whether the antioxidant activities of 
M. charantia fruit and its related constituents are media-
ted by an increase in antioxidant enzymes, we measured 
SOD, CAT and GPx and GST activities in different 
tissues of rats treated with M. charantia fruit extract. In 
the present study, treatment of rats with M. charantia fruit 
extract significantly increased rat liver, lung and kidney 
SOD, CAT and GPx activities (Table 2). There were 
significant (p<0.001) increase in all hepatic CAT, SOD 
and GPx activities. More than four-fold increases were 
observed with M. charantia fruit extract treatment in 
hepatic antioxidant enzymes suggesting that liver plays 
predominant role in protection against free radicals. 
Although similar significant levels of elevations were 
observed in GPx activities in different tissues, CAT and 
SOD activities were found to be increased to lesser 
degrees in kidney and lung tissues (Table 2). SOD, CAT 
and GPx are major free radical scavenging enzymes that 
have shown to be reduced in a number of pathophy-
siological processes and diseases such as diabetes 
(Cohen and Heikkila, 1994). Thus, activation of these 
AOE by the administration of M. charantia fruit extract 
clearly shows that M. charantia fruit contains free radical 
scavenging activity, which could exert a beneficial action 
against pathophysiological alterations caused by the 
presence of superoxide and hydroxide radicals. 
In addition M. charantia fruit extract caused significant 
(p<0.01) elevations on hepatic and nephritic cytosolic 
GSTs which are responsible for the metabolism of 
numerous xenobiotics and play a major cellular antioxi-
dant role. GSTs also have peroxidase and isomerase 
activity; they bind covalently with reactive metabolites 
formed from carcinogens and noncovalently with 
lipophilic compounds, thereby offering protection against 
oxidative stress (Hayes and Pulford, 1995). 
In this study we have also attempted to examine 
whether M. charantia fruit extract were able to affect 
some CYP isoforms in male rat livers by using highly 
specific substrates to CYP isozymes. Treatments of rats




Table 1. The effects of M. charantia fruit extracts on serum LDH, AST and ALT. 
 
Enzyme activities (Units) 
Groups 
LDH AST ALT 
Control 670 ± 96 188.85 ±29 152.22 ± 19 
Momordica 690 ± 90* 142.93 ± 15* 117.78 ± 14* 
CCl4 1,680 ± 166*** 528.30 ± 74*** 406.81 ± 63*** 
CCl4 + Momordica 210 ± 15* 185.33 ± 21* 164.17 ± 16* 
 




Table 2. The effects of M. charantia fruit extracts on anti-oxidant enzyme activities. 
 
Liver Kidney Lung 
Enzymes 
Control Momordica Control Momordica Control Momordica 
CAT (nmol/min/mg protein) 19.47 ± 2.79 92.01 ± 9.13*** 11.79 ± 2.79 24.17 ± 3.17** 14.24 ± 1.84 3.12 ± 0.87* 
GPx (nmol/min/mg protein) 0.96 ± 0.26 4.77 ± 0.44*** 0.41 ± 0.10 3.42 ± 0.13*** 1.18 ± 0.24 2.67 ± 0.19*** 
GST (nmol/min/mg protein) 257.8 ± 13.6 365.9 ± 27.6** 77.6 ± 4.4 150.3 ± 7.5** 156.7 ± 6.8 148.2 ± 10.9* 
SOD (Unit/mg protein) 1.21 ± 0.06 5.09 ± 0.09*** 0.23 ± 0.05 0.28 ± 0.05** ND ND 
 




with M. charantia significantly reduced both EROD 
(p<0.01) and MROD (p<0.05) activities in rat liver micro-
somes, which are known to be catalyzed by CYP1A iso-
forms (Table 3). Although species differences make it 
difficult to extrapolate the inhibitions from rats to human, 
selective inhibition of CYP1A isoforms could be consi-
dered as one possible mechanism of the chemo-protec-
tive action of M. charantia because they are pri-marily 
involved in the metabolism and activation of carci-nogens 
and procarcinogens (Ioannides and Lewis, 2004). In 
addition, caution should be paid to the possible drug 
interactions in people who concurrently using M. charan-
tia. However, further studies are required to be carried 
out on this CYP field to clearly elucidate which isoforms 
and how they are involved in the modulatory eff-ects. 
These findings clearly demonstrated the antioxidant 
and chemoprotective activities of M. charantia fruit extract 
in experimental rat models. Although further studies are 
required to identify active components involved in the 
antioxidant and chemoprotective activity of this fruit, 
results strongly suggest that M. charantia fruit extract has 
chemoprotective action against CCl4-induced toxicity. In 
addition, even if it is indirect, inhibition of CYP1A 
dependent activities could be considered as a promising 
cancer chemoproventive action by lowering metabolic 
activation of various carcinogens and/or procarcinogens. 
Based on our knowledge, the present study is the first 
reporting the effect of M. charantia fruit extract on CYP1A 
dependent enzyme activities, namely EROD and MROD. 
In conclusion, the present study showed that in vivo 
treatment of rats with M. charantia fruit extract enhanced 
both AOE and GST activities while lowering CYP1A 
dependent enzyme activities. 
Table 3. The effects of M. charantia fruit extracts on CYP1A 
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